Articles by author - Martin Prázný

Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.

Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R.

Controlled Clinical Trial 2008; 29(1): 146-150 PubMed PMID: 18283261  Keywords:  Aged, Biomarkers:blood, Cardiovascular Diseases:blood, Cholesterol, LDL:blood, Diabetes Mellitus, Type 2:blood, Female, Fenofibrate:adverse effects, Humans, Lipoproteins:blood, Male, Middle Aged, Peroxisome Proliferator-Activated Receptors:agonists, Phosp.    Citation

BACKGROUND: Particle size distribution in both HDL and LDL is reflected in the fractional esterification rate of cholesterol by lecithin c.....

Read abstract  Full text PDF

Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.

Prázný M, Fait T, Vrablik M.

Comparative Study 2007; 28(4): 496-501 PubMed PMID: 17693976  Keywords:  Administration, Oral, Administration, Topical, Adult, Capillaries:drug effects, Cholesterol, HDL:blood, Cholesterol, LDL:blood, Cross-Over Studies, Estradiol:administration & dosage, Estrogen Replacement Therapy:methods, Estrogens:administration & dosage,.    Citation

OBJECTIVES: The aim of the study was to evaluate skin microvascular reactivity (MVR) measured by laser Doppler flowmetry in women early af.....

Read abstract  Full text PDF